Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen.
作者信息
Ding Han, Wang Jian, Zhang Yichi, Zhao Shuai, Han Bing, Cai Hao, Gu Jinyang
机构信息
Department of Transplantation, Xinhua Hospital Affifiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Hepatobiliary Surg Nutr. 2022 Jun;11(3):498-501. doi: 10.21037/hbsn-21-454.
Abstract
摘要
相似文献
1
Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen.活体供肝肝移植联合脾切除术治疗1例B型尼曼-皮克病患儿：围手术期抗凝方案的单中心经验
Hepatobiliary Surg Nutr. 2022 Jun;11(3):498-501. doi: 10.21037/hbsn-21-454.
2
The Effects of Liver Transplantation in Children With Niemann-Pick Disease Type B.尼曼-匹克病 B 型患儿肝移植的疗效。
Liver Transpl. 2019 Aug;25(8):1233-1240. doi: 10.1002/lt.25457. Epub 2019 Jun 25.
3
[Acid sphingomyelinase deficiency and spleen trauma: splenectomy or not splenectomy?].[酸性鞘磷脂酶缺乏与脾外伤：脾切除术还是不做脾切除术？]
Rev Med Interne. 2015 Sep;36(9):619-22. doi: 10.1016/j.revmed.2014.10.367. Epub 2014 Nov 5.
4
Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen.尼曼-匹克病的生化研究。I.肝脏和脾脏中的主要鞘脂。
Biochim Biophys Acta. 1983 Jan 7;750(1):178-84. doi: 10.1016/0005-2760(83)90218-7.
5
Morbidity and mortality in type B Niemann-Pick disease.B 型尼曼-匹克病的发病率和死亡率。
Genet Med. 2013 Aug;15(8):618-23. doi: 10.1038/gim.2013.4. Epub 2013 Feb 14.
6
[Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].成年期酸性鞘磷脂酶缺乏症（尼曼-匹克病B型）：28例成年病例的回顾性多中心研究
Rev Med Interne. 2017 May;38(5):291-299. doi: 10.1016/j.revmed.2016.10.387. Epub 2016 Nov 22.
7
Liver Transplantation in Patients With Niemann-Pick Disease--Single-Center Experience.尼曼-匹克病患者的肝移植——单中心经验
Transplant Proc. 2015 Dec;47(10):2929-31. doi: 10.1016/j.transproceed.2015.10.051.
8
Cirrhosis and portal hypertension in a patient with adult Niemann-Pick disease.一名成年尼曼-匹克病患者的肝硬化和门静脉高压症
Gastroenterology. 1991 Feb;100(2):567-9. doi: 10.1016/0016-5085(91)90233-b.
9
Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation.通过异基因骨髓移植治疗B型尼曼-匹克病。
Br Med J (Clin Res Ed). 1987 Nov 28;295(6610):1375-6. doi: 10.1136/bmj.295.6610.1375.
10
[Niemann-Pick disease and splenectomy].[尼曼-匹克病与脾切除术]
Ann Ital Chir. 1951 Jan-Feb;28(1-2):80-7.
本文引用的文献
1
The Effects of Liver Transplantation in Children With Niemann-Pick Disease Type B.尼曼-匹克病 B 型患儿肝移植的疗效。
Liver Transpl. 2019 Aug;25(8):1233-1240. doi: 10.1002/lt.25457. Epub 2019 Jun 25.
2
Perioperative anticoagulation practices for pediatric liver transplantation.小儿肝移植围手术期抗凝治疗实践
Pediatr Transplant. 2018 Jun;22(4):e13193. doi: 10.1111/petr.13193. Epub 2018 Apr 16.
3
Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy.肝硬化门静脉高压症患者脾切除术后门静脉系统血栓形成的预测模型
Int J Clin Exp Med. 2015 Mar 15;8(3):4236-42. eCollection 2015.
4
Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.肝硬化患者脾切除术后门静脉血栓形成的危险因素及临床特征。
Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):512-9. doi: 10.1016/s1499-3872(13)60081-8.
5
Morbidity and mortality in type B Niemann-Pick disease.B 型尼曼-匹克病的发病率和死亡率。
Genet Med. 2013 Aug;15(8):618-23. doi: 10.1038/gim.2013.4. Epub 2013 Feb 14.
6
Liver transplantation in a patient with Niemann-Pick disease and pulmonary involvement.尼曼-匹克病合并肺部受累患者的肝移植
J Bras Pneumol. 2012 Mar-Apr;38(2):269-71. doi: 10.1590/s1806-37132012000200018.
7
The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.酸性鞘磷脂酶缺乏型尼曼-匹克病的发病机制与治疗
J Inherit Metab Dis. 2007 Oct;30(5):654-63. doi: 10.1007/s10545-007-0632-9. Epub 2007 Jul 12.
8
Age-related differences in heparin response.肝素反应的年龄相关差异。
Thromb Res. 2006;118(6):741-5. doi: 10.1016/j.thromres.2005.11.004. Epub 2005 Dec 19.
9
Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.活体肝移植后的凝血和纤溶指标以及肝素的合理使用
Clin Transplant. 2005 Dec;19(6):804-9. doi: 10.1111/j.1399-0012.2005.00425.x.
10
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.肝素与低分子量肝素：作用机制、药代动力学、给药考量、监测、疗效及安全性
Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s.
Zotero 插件